Intra-aortic balloon pump improves clinical prognosis and attenuates C-reactive protein level in acute STEMI complicated by cardiogenic shock

Cardiology

Volumn 117, Issue 1, 2010, Pages 75-80

  Gu, Jun ^a   Hu, Wei ^a   Xiao, Hongbing ^a   Feng, Xiaodi ^a   Chen, Yueguang ^a   Zhang, Dadong ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b NONE   (China)

Author keywords

Acute myocardial infarction; C reactive protein; Cardiogenic shock; Percutaneous coronary intervention

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERTENSIVE AGENT; INOTROPIC AGENT; TROPONIN I;

ADULT; AGED; ANTICOAGULANT THERAPY; AORTA BALLOON; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; EMBOLISM; EMERGENCY TREATMENT; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SPLEEN EMBOLISM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT OUTCOME; VASCULAR DISEASE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INTRA-AORTIC BALLOON PUMPING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; SHOCK, CARDIOGENIC; TREATMENT OUTCOME; TROPONIN I; VENTRICULAR FUNCTION, LEFT;

EID: 77957319673     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319618     Document Type: Article

References (23)

1. Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA, Godfrey E, White HD, Lim J, LeJemtel T: Cardiogenic shock complicating acute myocardial infarction: etiologies, management and outcome: a report from the SHOCK trial registry. J Am Coll Cardiol 2000; 36:1063-1070.
2. Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, Chou TM; Investigators in the National Registry of Myocardial Infarction 2: The use of intra-aortic balloon counterpulsation in patients with cardio-genic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J 2001; 141:933-939.
3. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Hal-perin JL, Hiratzka LF, Hunt SA, Jacobs AK; American College of Cardiology; American Heart Association Task Force on Practice Guidelines; Canadian Cardiovascular Society: ACC/AHA guidelines for the management of patients with ST-elevation myocar-dial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110:e82-e292.
4. Van de Werf F, Ardissino D, Betriu A, Cok-kinos DV, Falk E, Fox KA, Julian D, Lengyel M, Neumann FJ, Ruzyllo W, Thygesen C, Underwood SR, Vahanian A, Verheugt FW, Wijns W: Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2003; 24:28-66.
5. Libby P, Ridker PM, Maseri A: Inf lammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
6. Bae EH, Lim SY, Jeong MH, Park HW, Lim JH, Hong YJ, Kim W, Kim JH, Cho JG, Ahn YK, Park JC, Suh SP, Ahn BH, Kim SH, Kang JC: Long-term predictive factors of major adverse cardiac events in patients with acute myocardial infarction complicated by car-diogenic shock. Korean J Intern Med 2005; 20: 8-14.
7. Mishra S, Chu WW, Torguson R, Wolfram R, Deible R, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R: Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol 2006; 98:608-612.
8. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH: Early revascularization in acute myo-cardial infarction complicated by cardiogen-ic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coro-naries for Cardiogenic Shock? N Engl J Med 1999; 341: 625-634.
9. Waksman R, Weiss AT, Gotsman MS, Hasin Y: Intra-aortic balloon cou nter pulsation improves survival in cardiogenic shock complicating acute myocardial infarction. Eur Heart J 1993; 14 : 71-74.
10. Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, Dens J, Dzavik V, Palmeri ST, Webb JG, Goldberger M, Hoch-man JS: Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coro-naries for cardiogenic shocK? J Am Coll Car-diol 2000; 36:1123-1129.
11. Kovack PJ, Rasak MA, Bates ER, Ohman EM, Stomel RJ: Thrombolysis plus aortic coun-terpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol 1997; 29:1454-1458.
12. Anderson RD, Ohman EM, Holmes DR Jr, Col I, Stebbins AL, Bates ER, Stomel RJ, Granger CB, Topol EJ, Califf RM: Use of in-traaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol 1997; 30:708-715.
13. Low R: Intra-aortic balloon counterpulsation in acute myocardial infarction: too few or too many? J Am Coll Cardiol 2003; 41: 1946-1947.
14. Ohman EM, Nanas J, Stomel RJ, Leesar MA, Nielsen DW, O'Dea D, Rogers FJ, Harber D, Hudson MP, Fraulo E, Shaw LK, Lee KL; TACTICS Trial: Thrombolysis and counter-pulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thrombosis Thrombolysis 2005; 19: 33-39.
15. Sjauw KD, Engström AE, Vis MM, van der Schaaf RJ, Baan J Jr, Koch KT, de Winter RJ, Piek JJ, Tijssen JG, Henriques JP: A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myo-cardial infarction: should we change the guidelines? Eur Heart J 2009;30: 459-468.
16. Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter JM, Russ M, Schlitt A, Buerke U, Christoph A, Schmidt H, Winkler M, Thiery J, Werdan K, Buerke M: Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010; 38:152-160.
17. Dimitrijevic O, Stojcevski BD, Ignjatovic S, Singh NM: Serial measurements of C-reac-tive protein after acute myocardial infarction in predicting one-year outcome. Int Heart J 2006; 47: 833-842.
18. Dibra A, Mehilli J, Braun S, Hadamitzky M, Bau m H, Di rschinger J, Schüh len H, Schömig A, Kastrati A: Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with reste-nosis in patients treated with coronary stent-ing. Am Heart J 2005; 150: 344-350.
19. Akkus MN, Polat G, Yurtdas M, Akcay B, Er-cetin N, Cicek D, Doven O, Sucu N: Admission levels of C-reactive protein and plas-minogen activator inhibitor-1 in patients with acute myocardial infarction with and without cardiogenic shock or heart failure on admission. Int Heart J 2009; 50:33-45.
20. Onorati F, Santarpino G, Tangredi G, Pal-mieri G, Rubino AS, Foti D, Gulletta E, Ren-zulli A: Intra-aortic balloon pump induced pulsatile perfusion reduces endothelial activation and inf lammatory response following cardiopulmonary bypass. Eur J Cardiotho-rac 2009; 35: 1012-1019.
21. Roubille F, Cayla G, Picot MC, Pradet V, Massin F, Gervasoni R, Pasquie JL, Macia JC, Piot C, Leclercq F: C-reactive protein (CRP) after revascularized STEMI: is CRP a prognostic factor? Rev Med Interne 2008; 29:868-874.
22. Hoffmann R, Suliman H, Haager P, Chris-tott P, Lepper W, Radke PW, Ortlepp J, Blindt R, Hanrath P, Weber C: Association of C-re-active protein and myocardial perfusion in patients with ST-elevation acute myocardial infarction. Atherosclerosis 2006; 86:177-183.
23. Majstorov V, Pop Gjorceva D, Vaskova O, Vavlukis M, Peovska I, Maksimovic J, Kuz-manovska S, Zdraveska-Kocovska M: C-re-active protein in patients with normal perfu-sion and mild to moderate perfusion defects who have undergone myocardial perfusion imaging with 99m-Tc sestamibi gated spect. Prilozi 2008; 29:67-76.